02/06/2006 - KEM 1.0 is released
ScriboScience is pleased to announce that Ariana Pharmaceuticals released KEM 1.0 today.
KEM is a decision support tool which is used for the rapid identification and optimization of novel, drug-like small molecules and it features comprehensive online help by ScriboScience.
"The release of KEM 1.0 is a significant milestone for Mohammad and his team at Ariana." said Vanessa Hoy, Director of ScriboScience. "And it is also a significant milestone for ScriboScience. This is our first comprehensive commercial help system. We have worked closely with the Ariana team on this project and I think the collaboration has resulted in a quality help system for KEM's users."